Roche extends hostile bid for Ventana
This article was originally published in The Gray Sheet
Executive Summary
Tissue-based cancer test firm Ventana continues to dismiss Roche's $3 billion unsolicited takeover offer as "grossly inadequate" after Roche extends its $75-per-share bid for a third time on Sept. 19 - this time until Nov. 1. The offer, launched in June, had been slated to expire Sept. 20. The 63,500 Ventana shares tendered to date represent just 0.19% of the company (1"The Gray Sheet" Aug. 27, 2007, In Brief)